Cite
HARVARD Citation
Scott, R. et al. (2022). Outcomes following biosimilar TNF inhibitor use for inflammatory-mediated immune disorders in pregnancy. Obstetric medicine. pp. 104-107. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Scott, R. et al. (2022). Outcomes following biosimilar TNF inhibitor use for inflammatory-mediated immune disorders in pregnancy. Obstetric medicine. pp. 104-107. [Online].